Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. (KRTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · KRTX · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
53
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Karuna Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
KRTX insider buying and selling by quarter
KRTX insider selling · KRTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
KRTX executive sell shares · KRTX board member insider trading · KRTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 18, 2024 | Wheadon David E. Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | Torres Denice Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | Pande Atul Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | OLSON LAURIE J Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | JONAS JEFFREY M Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | HEALY JAMES Director | Other | 32,500 | $10.72M⚡ | Form 4 |
| Mar 18, 2024 | HEALY JAMES Director | Other | 8,025 | $2.65M⚡ | Form 4 |
| Mar 18, 2024 | Miller Andrew Craig President of R&D | Other | 13,977 | $4.61M⚡ | Form 4 |
| Mar 18, 2024 | PAUL STEVEN M Director | Other | 2,046 | $675K | Form 4 |
| Mar 18, 2024 | PAUL STEVEN M Director | Other | 35,877 | $11.84M⚡ | Form 4 |
| Mar 18, 2024 | Miller Andrew Craig President of R&D | Other | 9,412 | $3.11M⚡ | Form 4 |
| Mar 18, 2024 | COUGHLIN CHRISTOPHER J Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | Brown Jason Parker CFO | Other | 14,009 | $4.62M⚡ | Form 4 |
| Mar 18, 2024 | Brown Jason Parker CFO | Other | 7,158 | $2.36M⚡ | Form 4 |
| Mar 18, 2024 | Meury William President and CEO · Director | Other | 10,342 | $3.41M⚡ | Form 4 |
| Mar 18, 2024 | Meury William President and CEO · Director | Other | 19,037 | $6.28M⚡ | Form 4 |
| Mar 18, 2024 | Kane William P Jr Chief Commercial Officer | Other | 5,000 | $1.65M⚡ | Form 4 |
| Mar 18, 2024 | Kane William P Jr Chief Commercial Officer | Other | 8,828 | $2.91M⚡ | Form 4 |
| Mar 18, 2024 | Brannan Stephen K. Chief Medical Officer | Other | 36,117 | $11.92M⚡ | Form 4 |
| Mar 18, 2024 | Brannan Stephen K. Chief Medical Officer | Other | 6,487 | $2.14M⚡ | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Option | 1,791 | $201K | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Option | 3,209 | $422K | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Sale | 4,900 | $1.56M⚡ | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Sale | 100 | $32K | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Option | 2,500 | $14K | Form 4 |
Miller Andrew Craig
President of R&D
Date
Mar 18
Shares
13,977
Price
$330.00
Value
$4.61M ⚡
Miller Andrew Craig
President of R&D
Date
Mar 18
Shares
9,412
Price
$330.00
Value
$3.11M ⚡
Meury William
President and CEO · Director
Date
Mar 18
Shares
10,342
Price
$330.00
Value
$3.41M ⚡
Meury William
President and CEO · Director
Date
Mar 18
Shares
19,037
Price
$330.00
Value
$6.28M ⚡
Kane William P Jr
Chief Commercial Officer
Date
Mar 18
Shares
5,000
Price
$330.00
Value
$1.65M ⚡
Kane William P Jr
Chief Commercial Officer
Date
Mar 18
Shares
8,828
Price
$330.00
Value
$2.91M ⚡
Brannan Stephen K.
Chief Medical Officer
Date
Mar 18
Shares
36,117
Price
$330.00
Value
$11.92M ⚡
Brannan Stephen K.
Chief Medical Officer
Date
Mar 18
Shares
6,487
Price
$330.00
Value
$2.14M ⚡
Brannan Stephen K.
Chief Medical Officer
Date
Mar 8
Shares
1,791
Price
$111.97
Value
$201K
Brannan Stephen K.
Chief Medical Officer
Date
Mar 8
Shares
3,209
Price
$131.64
Value
$422K
Brannan Stephen K.
Chief Medical Officer
Date
Mar 8
Shares
4,900
Price
$318.33
Value
$1.56M ⚡
Brannan Stephen K.
Chief Medical Officer
Date
Mar 8
Shares
100
Price
$318.96
Value
$32K
Brannan Stephen K.
Chief Medical Officer
Date
Mar 8
Shares
2,500
Price
$5.45
Value
$14K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About KRTX insider trading
KRTX insider trades
Karuna Therapeutics, Inc. (KRTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including KRTX. Over the past 12 months, 0 insiders have filed transactions with the SEC. KRTX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Karuna Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
KRTX insider trading · 5 questionsThe insiders of Karuna Therapeutics, Inc. (KRTX) include executives and directors such as KRTX, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026